Pharma telehealth programs
Lawmakers Scrutinize Pharma’s Telehealth Marketing Tactics Amid Concerns Over Patent Abuse and High Drug Prices
Pharma telehealth programs, Patent abuse, High drug prices, Lawmaker scrutiny, Pharmaceutical industry practices